دورية أكاديمية

Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin.

التفاصيل البيبلوغرافية
العنوان: Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin.
المؤلفون: Tinahones, Francisco J., Molina-Vega, María, Parra-Barona, Juan, Flores-Le Roux, Juana, Gómez-Huelgas, Ricardo
المصدر: Diabetology & Metabolic Syndrome; 7/24/2019, Vol. 11 Issue 1, pN.PAG-N.PAG, 1p, 2 Charts, 2 Graphs
مصطلحات موضوعية: GLYCOSYLATED hemoglobin, TYPE 2 diabetes, HEMOGLOBINS, BLOOD sugar
مصطلحات جغرافية: SPAIN
مستخلص: Objective: To study the prevalence of postprandial hyperglycaemia (PPH) in type 2 diabetes mellitus (T2DM) patients treated with basal insulin, having fasting glucose < 130 mg/dL but HbA1c > 7.0% (53 mmol/mol). Methods: This was an observational prospective multicentric study conducted in Spain. During 2 weeks, patients recorded a 6-point self-measured blood glucose profile (before and 2 h after eating) every 2 days. PPH was defined according to IDF and ADA guidelines (> 160 and > 180 mg/dL, respectively). Results: We included 98 patients (males: 56.1%; mean age: 64.3 ± 10.4 years) who were treated with basal insulin for at least 1 year at stable doses in the last 2 months, 88.8% of them received concomitant oral antidiabetic drugs. Overall, 95.7% (95% CI 91.6–99.8) and 93.5% (95% CI 88.6–98.5) of patients showed ≥ 1 episode of PPH according to IDF and ADA criteria respectively. PPH was more frequently observed after lunch and dinner. The proportion of patients with ≥ 40% readings in range of PPH was 59.1% (95% CI 49.1–69.1) and 40.9% (95% CI 30.9–50.9), according to IDF and ADA criteria, respectively. Conclusions: PPH is very common and should be considered a priority target in basal insulin-treated T2DM patients with elevated HbA1c despite controlled fasting glucose. [ABSTRACT FROM AUTHOR]
Copyright of Diabetology & Metabolic Syndrome is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17585996
DOI:10.1186/s13098-019-0452-8